The combination of vitamin C and grape-seed polyphenols increases blood pressure: a randomized, double-blind, placebo-controlled trial
Authors:
- Natalie C WardNWNatalie C Ward
- Jonathan M HodgsonJHJonathan M Hodgson
- Kevin D CroftKCKevin D Croft
- Valerie BurkeVBValerie Burke
- Lawrence J BeilinLBLawrence J Beilin
- Ian B PuddeyIPIan B Puddey
- 1 February 2005
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 23 (2) , 427-434
Abstract
There is growing evidence that oxidative stress contributes to the pathogenesis of hypertension and endothelial dysfunction. Thus, dietary antioxidants may beneficially influence blood pressure (BP) and endothelial function by reducing oxidative stress. To determine if vitamin C and polyphenols, alone or in combination, can lower BP, improve endothelial function and reduce oxidative stress in hypertensive individuals. A total of 69 treated hypertensive individuals with a mean 24-h ambulatory systolic blood pressure ≥ 125 mmHg participated in a randomized, double-blind, placebo-controlled, factorial trial. Following a 3-week washout, participants received 500 mg/day vitamin C, 1000 mg/day grape-seed polyphenols, both vitamin C and polyphenols, or neither for 6 weeks. At baseline and post-intervention, 24-h ambulatory BP, ultrasound-assessed endothelium-dependent and -independent vasodilation of the brachial artery, and markers of oxidative damage, (plasma and urinary F2-isoprostanes, oxidized low-density lipoproteins and plasma tocopherols), were measured. A significant interaction between grape-seed and vitamin C treatments for effects on BP was observed. Vitamin C alone reduced systolic BP versus placebo (−1.8 ± 0.8 mmHg, P = 0.03), while polyphenols did not (−1.3 ± 0.8 mmHg, P = 0.12). However, treatment with the combination of vitamin C and polyphenols increased systolic BP (4.8 ± 0.9 mmHg versus placebo; 6.6 ± 0.8 mmHg versus vitamin C; 6.1 ± 0.9 mmHg versus polyphenols mmHg, each P < 0.0001) and diastolic BP (2.7 ± 0.6 mmHg, P < 0.0001 versus placebo; 1.5 ± 0.6 mmHg, P = 0.016 versus vitamin C; 3.2 ± 0.7 mmHg, P < 0.0001 versus polyphenols). Endothelium-dependent and -independent vasodilation, and markers of oxidative damage were not significantly altered. Although the mechanism remains to be elucidated, these results suggest caution for hypertensive subjects taking supplements containing combinations of vitamin C and polyphenols.Keywords
This publication has 40 references indexed in Scilit:
- Chocolate and Blood Pressure in Elderly Individuals With Isolated Systolic HypertensionJAMA, 2003
- Lack of Long-Term Effect of Vitamin C Supplementation on Blood PressureHypertension, 2002
- A randomized, double-blind, placebo-controlled, prospective, 16 week crossover study to determine the role of Pycnogenol in modifying blood pressure in mildly hypertensive patientsNutrition Research, 2001
- Effect of vitamin C on ambulatory blood pressure and plasma lipids in older personsJournal Of Hypertension, 2000
- Treatment of hypertension with ascorbic acidThe Lancet, 1999
- Effects of isoflavonoids on blood pressure in subjects with high-normal ambulatory blood pressure levels A randomized controlled trialAmerican Journal of Hypertension, 1999
- Vitamin C Improves Endothelium-Dependent Vasodilation by Restoring Nitric Oxide Activity in Essential HypertensionCirculation, 1998
- Vitamin C and blood pressure–an overviewJournal of Human Hypertension, 1997
- A Double-Blind, Placebo-Controlled Parallel Trial of Vitamin C Treatment in Elderly Patients with HypertensionGerontology, 1994
- Abnormal Endothelium-Dependent Vascular Relaxation in Patients with Essential HypertensionNew England Journal of Medicine, 1990